Trace Element Replenishment Study in Hemodialysis Patients

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 150 participants.

Also called NCT01473914

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 150 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01473914
Main results
  • Trace element supplementation in hemodialysis patients: a randomized controlled trial BMC nephrology, 2015-04-11 DOI, PubMed 25884981, PMC4409771 In the PMC Open Access subset under CC BY.

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Canada (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01473914. Randomized; quadruple masking; primary purpose treatment. Start 2012-11 (registry gives no type); primary completion 2013-12 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Trace Element Replenishment Study in Hemodialysis Patients
Condition
End Stage Renal Disease
Intervention (Dietary supplement)
Low dose: supplemental zinc, selenium and vitamin E
Intervention (Dietary supplement)
Standard renal vitamin: B and C renal vitamin
Intervention (Dietary supplement)
Medium dose: supplemental zinc, selenium and vitamin E
Lead sponsor
Marcello Tonelli (class: other)
Collaborator
Alberta Health services (class: other)

Record details

Record id
cardio:ct-nct01473914
Content hash
5537107ff12658da7fee2ee214414ac4e2108e85f12d96645cd7a5c562a0eee3